Congress Reacts to Medicine Recall
The House Committee on Oversight and Government Reform has opened an investigation into the recent recall of children’s over-the-counter defective medicines, according to media reports.
Recently, a division of Johnson & Johnson issued a product recall for more than 40 types of children’s and infants’ medicines. The Food and Drug Administration, or FDA, subsequently cited deficiencies at the division’s Pennsylvania plant that could have caused bacterial contamination of raw materials in the recalled pharmaceutical products.
An FDA report listed more than 20 manufacturing problems at the plant. Including not properly testing for contamination. The FDA also said that the Johnson & Johnson unit received 46 consumer complaints from June 2009 up to April about foreign materials in the drugs, but failed to take corrective action.
The circumstances behind this recall certainly justify congressional interest. Unfortunately, no congressional probe can restore the health of a child who may have suffered personal injury from defective medicine.
At Schlichter, Bogard & Denton, we know that consumers of defective medicine are at risk, and children even more so. It is simply basic justice to hold the maker of faulty medical products responsible for any injury they may cause. If you or a family member has been the victim of such faulty products, we urge you to contact us for a confidential, no-cost discussion of your case at any of our nationwide offices.